ASX - By Stock
|
AVH |
Re:
Ann: Change of Director's Interest Notice - Michael Perry
|
|
avetis
|
13 |
4.8K |
3 |
30/11/22 |
30/11/22 |
ASX - By Stock
|
13
|
4.8K
|
3
|
|
ASX - By Stock
|
AVH |
Re:
Ann: Change of Director's Interest Notice - Michael Perry
|
|
avetis
|
13 |
4.8K |
2 |
30/11/22 |
30/11/22 |
ASX - By Stock
|
13
|
4.8K
|
2
|
|
ASX - By Stock
|
AVH |
Re:
Ann: Change of Director's Interest Notice - Michael Perry
|
|
avetis
|
13 |
4.8K |
2 |
30/11/22 |
30/11/22 |
ASX - By Stock
|
13
|
4.8K
|
2
|
|
ASX - By Stock
|
AVH |
Re:
US might be waking up
|
|
avetis
|
79 |
34K |
4 |
24/11/22 |
24/11/22 |
ASX - By Stock
|
79
|
34K
|
4
|
|
ASX - By Stock
|
AVH |
Re:
Ann: AVITA Medical Reports Third Quarter 2022 Financial Results
|
|
avetis
|
79 |
35K |
1 |
14/11/22 |
14/11/22 |
ASX - By Stock
|
79
|
35K
|
1
|
|
ASX - By Stock
|
AVH |
Re:
Ann: AVITA Medical Reports Third Quarter 2022 Financial Results
|
|
avetis
|
79 |
35K |
3 |
12/11/22 |
12/11/22 |
ASX - By Stock
|
79
|
35K
|
3
|
|
ASX - By Stock
|
AVH |
Re:
Ann: AVITA Medical Reports Third Quarter 2022 Financial Results
|
|
avetis
|
79 |
35K |
4 |
12/11/22 |
12/11/22 |
ASX - By Stock
|
79
|
35K
|
4
|
|
ASX - By Stock
|
AVH |
Re:
Ann: AVITA Medical Reports Third Quarter 2022 Financial Results
|
|
avetis
|
79 |
35K |
7 |
11/11/22 |
11/11/22 |
ASX - By Stock
|
79
|
35K
|
7
|
|
ASX - By Stock
|
AVH |
Re:
AVITA Medical Reports Third Quarter 2022 Financial Results
|
|
avetis
|
10 |
4.1K |
2 |
11/11/22 |
11/11/22 |
ASX - By Stock
|
10
|
4.1K
|
2
|
|
ASX - By Stock
|
AVH |
Re:
AVITA Medical achieves co-primary endpoints in updated RECELL trial
|
|
avetis
|
26 |
8.9K |
4 |
10/11/22 |
10/11/22 |
ASX - By Stock
|
26
|
8.9K
|
4
|
|
ASX - By Stock
|
AVH |
Re:
FDA Breakthrough Device Designations for VITILIGO & Soft Tissue for the RECELL® System
|
|
avetis
|
43 |
15K |
0 |
09/11/22 |
09/11/22 |
ASX - By Stock
|
43
|
15K
|
0
|
|
ASX - By Stock
|
AVH |
Re:
FDA Breakthrough Device Designations for VITILIGO & Soft Tissue for the RECELL® System
|
|
avetis
|
43 |
15K |
0 |
04/11/22 |
04/11/22 |
ASX - By Stock
|
43
|
15K
|
0
|
|
ASX - By Stock
|
AVH |
Re:
Ann: Definitive Proxy Statement
|
|
avetis
|
18 |
3.8K |
4 |
21/10/22 |
21/10/22 |
ASX - By Stock
|
18
|
3.8K
|
4
|
|
ASX - By Stock
|
AVH |
Re:
Enterprise Value
|
|
avetis
|
601 |
183K |
4 |
17/10/22 |
17/10/22 |
ASX - By Stock
|
601
|
183K
|
4
|
|
ASX - By Stock
|
AVH |
Re:
Ann: AVITA Medical Appoints James Corbett as CEO
|
|
avetis
|
147 |
41K |
0 |
10/10/22 |
10/10/22 |
ASX - By Stock
|
147
|
41K
|
0
|
|
ASX - By Stock
|
AVH |
Re:
Ann: AVITA Medical Appoints James Corbett as CEO
|
|
avetis
|
147 |
41K |
2 |
09/10/22 |
09/10/22 |
ASX - By Stock
|
147
|
41K
|
2
|
|
ASX - By Stock
|
AVH |
Re:
Ann: AVITA Medical Appoints James Corbett as CEO
|
|
avetis
|
147 |
41K |
0 |
08/10/22 |
08/10/22 |
ASX - By Stock
|
147
|
41K
|
0
|
|
ASX - By Stock
|
AVH |
Re:
Ann: AVITA Medical Appoints James Corbett as CEO
|
|
avetis
|
147 |
41K |
0 |
07/10/22 |
07/10/22 |
ASX - By Stock
|
147
|
41K
|
0
|
|
ASX - By Stock
|
AVH |
Re:
Ann: AVITA Medical Appoints James Corbett as CEO
|
|
avetis
|
147 |
41K |
3 |
07/10/22 |
07/10/22 |
ASX - By Stock
|
147
|
41K
|
3
|
|
ASX - By Stock
|
AVH |
Re:
Ann: AVITA Medical Appoints James Corbett as CEO
|
|
avetis
|
147 |
41K |
0 |
07/10/22 |
07/10/22 |
ASX - By Stock
|
147
|
41K
|
0
|
|
ASX - By Stock
|
AVH |
Re:
Ann: AVITA Medical Appoints James Corbett as CEO
|
|
avetis
|
147 |
41K |
0 |
07/10/22 |
07/10/22 |
ASX - By Stock
|
147
|
41K
|
0
|
|
ASX - By Stock
|
AVH |
Re:
Ann: AVITA Medical Appoints James Corbett as CEO
|
|
avetis
|
147 |
41K |
1 |
07/10/22 |
07/10/22 |
ASX - By Stock
|
147
|
41K
|
1
|
|
ASX - By Stock
|
AVH |
Re:
Ann: AVITA Medical Appoints James Corbett as CEO
|
|
avetis
|
147 |
41K |
3 |
06/10/22 |
06/10/22 |
ASX - By Stock
|
147
|
41K
|
3
|
|
ASX - By Stock
|
AVH |
Re:
Ann: AVITA Medical Appoints James Corbett as CEO
|
|
avetis
|
147 |
41K |
0 |
06/10/22 |
06/10/22 |
ASX - By Stock
|
147
|
41K
|
0
|
|
ASX - By Stock
|
AVH |
Re:
Ann: AVITA Medical Appoints James Corbett as CEO
|
|
avetis
|
147 |
41K |
1 |
02/10/22 |
02/10/22 |
ASX - By Stock
|
147
|
41K
|
1
|
|
ASX - By Stock
|
AVH |
Re:
Ann: AVITA Medical Appoints James Corbett as CEO
|
|
avetis
|
147 |
41K |
0 |
01/10/22 |
01/10/22 |
ASX - By Stock
|
147
|
41K
|
0
|
|
ASX - By Stock
|
AVH |
Re:
Ann: AVITA Medical Appoints James Corbett as CEO
|
|
avetis
|
147 |
41K |
1 |
01/10/22 |
01/10/22 |
ASX - By Stock
|
147
|
41K
|
1
|
|
ASX - By Stock
|
AVH |
Re:
Ann: AVITA Medical Appoints James Corbett as CEO
|
|
avetis
|
147 |
41K |
0 |
01/10/22 |
01/10/22 |
ASX - By Stock
|
147
|
41K
|
0
|
|
ASX - By Stock
|
AVH |
Re:
New ceo
|
|
avetis
|
8 |
3.0K |
2 |
29/09/22 |
29/09/22 |
ASX - By Stock
|
8
|
3.0K
|
2
|
|
ASX - By Stock
|
AVH |
Re:
Ann: AVITA Medical Appoints James Corbett as CEO
|
|
avetis
|
147 |
41K |
2 |
29/09/22 |
29/09/22 |
ASX - By Stock
|
147
|
41K
|
2
|
|
ASX - By Stock
|
AVH |
Re:
Ann: AVITA Medical Appoints James Corbett as CEO
|
|
avetis
|
147 |
41K |
5 |
29/09/22 |
29/09/22 |
ASX - By Stock
|
147
|
41K
|
5
|
|
ASX - By Stock
|
AVH |
Re:
Enterprise Value
|
|
avetis
|
601 |
183K |
3 |
29/09/22 |
29/09/22 |
ASX - By Stock
|
601
|
183K
|
3
|
|
ASX - By Stock
|
AVH |
Re:
Enterprise Value
|
|
avetis
|
601 |
183K |
1 |
29/09/22 |
29/09/22 |
ASX - By Stock
|
601
|
183K
|
1
|
|
ASX - By Stock
|
AVH |
Re:
Enterprise Value
|
|
avetis
|
601 |
183K |
2 |
25/09/22 |
25/09/22 |
ASX - By Stock
|
601
|
183K
|
2
|
|
ASX - By Stock
|
AVH |
Re:
Enterprise Value
|
|
avetis
|
601 |
183K |
3 |
25/09/22 |
25/09/22 |
ASX - By Stock
|
601
|
183K
|
3
|
|
ASX - By Stock
|
AVH |
Re:
Enterprise Value
|
|
avetis
|
601 |
183K |
1 |
25/09/22 |
25/09/22 |
ASX - By Stock
|
601
|
183K
|
1
|
|
ASX - By Stock
|
AVH |
Re:
Enterprise Value
|
|
avetis
|
601 |
183K |
7 |
25/09/22 |
25/09/22 |
ASX - By Stock
|
601
|
183K
|
7
|
|
ASX - By Stock
|
AVH |
Re:
Ann: Ceasing to be a substantial holder
|
|
avetis
|
32 |
7.3K |
0 |
21/09/22 |
21/09/22 |
ASX - By Stock
|
32
|
7.3K
|
0
|
|
ASX - By Stock
|
AVH |
Re:
Ann: Positive Trial Results Treating Stable Vitiligo With RECELL
|
|
avetis
|
102 |
25K |
2 |
20/09/22 |
20/09/22 |
ASX - By Stock
|
102
|
25K
|
2
|
|
ASX - By Stock
|
AVH |
Re:
Ann: Positive Trial Results Treating Stable Vitiligo With RECELL
|
|
avetis
|
102 |
25K |
1 |
18/09/22 |
18/09/22 |
ASX - By Stock
|
102
|
25K
|
1
|
|
ASX - By Stock
|
AVH |
Re:
Ann: Positive Trial Results Treating Stable Vitiligo With RECELL
|
|
avetis
|
102 |
25K |
2 |
17/09/22 |
17/09/22 |
ASX - By Stock
|
102
|
25K
|
2
|
|
ASX - By Stock
|
AVH |
Re:
Ann: Positive Trial Results Treating Stable Vitiligo With RECELL
|
|
avetis
|
102 |
25K |
5 |
16/09/22 |
16/09/22 |
ASX - By Stock
|
102
|
25K
|
5
|
|
ASX - By Stock
|
AVH |
Re:
Ann: Positive Trial Results Treating Stable Vitiligo With RECELL
|
|
avetis
|
102 |
25K |
4 |
15/09/22 |
15/09/22 |
ASX - By Stock
|
102
|
25K
|
4
|
|
ASX - By Stock
|
AVH |
Re:
Ann: Positive Trial Results Treating Stable Vitiligo With RECELL
|
|
avetis
|
102 |
25K |
2 |
14/09/22 |
14/09/22 |
ASX - By Stock
|
102
|
25K
|
2
|
|
ASX - By Stock
|
AVH |
Re:
Coverage Begins in Japan ~ Medical Device for Acute Burns and Donor Sites
|
|
avetis
|
17 |
4.4K |
4 |
04/09/22 |
04/09/22 |
ASX - By Stock
|
17
|
4.4K
|
4
|
|
ASX - By Stock
|
AVH |
Re:
Ann: RECELL Insurance Coverage Begins in Japan for Acute Burns
|
|
avetis
|
18 |
4.5K |
2 |
04/09/22 |
04/09/22 |
ASX - By Stock
|
18
|
4.5K
|
2
|
|
ASX - By Stock
|
AVH |
Re:
Coverage Begins in Japan ~ Medical Device for Acute Burns and Donor Sites
|
|
avetis
|
17 |
4.4K |
2 |
02/09/22 |
02/09/22 |
ASX - By Stock
|
17
|
4.4K
|
2
|
|
ASX - By Stock
|
AVH |
Re:
Coverage Begins in Japan ~ Medical Device for Acute Burns and Donor Sites
|
|
avetis
|
17 |
4.4K |
0 |
02/09/22 |
02/09/22 |
ASX - By Stock
|
17
|
4.4K
|
0
|
|
ASX - By Stock
|
AVH |
Re:
Coverage Begins in Japan ~ Medical Device for Acute Burns and Donor Sites
|
|
avetis
|
17 |
4.4K |
1 |
02/09/22 |
02/09/22 |
ASX - By Stock
|
17
|
4.4K
|
1
|
|
ASX - By Stock
|
AVH |
Re:
Biotech comparison using Numbers
|
|
avetis
|
28 |
11K |
2 |
30/08/22 |
30/08/22 |
ASX - By Stock
|
28
|
11K
|
2
|
|